Trials / Completed
CompletedNCT04345094
Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging
Randomized, Double-Blind Evaluation of Hexyresorcinol vs Hydroquinone for Photoaging
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 32 (actual)
- Sponsor
- Sytheon Ltd. · Industry
- Sex
- Female
- Age
- 35 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
Photoaging is a common concern within the cosmeceutical industry with many products that are available. One frequently used product is hydroquinone that is used to even skin tone. However, hydroquinone has several shortcomings. The ingredient is controversial for its potential safety issues and it has been banned in Europe. An alternative ingredient that has emerged for its potential use is hexyresorcinol for evening skin tone. Additionally, hexylresorcinol may have other photoaging benefits such as the reduction in the appearance of fine lines. Therefore, the aim of this study is to assess how hexyresorcinol may compare to the use of hydroquinone in the setting of photoaging.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Hexylresourcinol | Emulsion containing hexylresorcinol as an active |
| OTHER | Hydroquinone | Emulsions containing hydroquinone as an active |
Timeline
- Start date
- 2019-07-01
- Primary completion
- 2019-12-24
- Completion
- 2020-02-15
- First posted
- 2020-04-14
- Last updated
- 2020-07-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04345094. Inclusion in this directory is not an endorsement.